Uncategorized

Bubs Australia (ASX:BUB), a leading infant formula and baby food company, has announced the commencement of a nationwide clinical trial in the United States. This initiative marks a significant milestone in the company’s dedication to serving North American families. Bubs’ Growth Monitoring Study (GMS) clinical trial is designed to evaluate the growth, tolerance, and safety […]

Stocks sold off Wednesday, continuing the sluggish start to September, as concerns mounted that the Federal Reserve may not be done hiking interest rates. The Dow Jones Industrial Average sank 198.78 points, or 0.57 per cent, to end at 34,443.19. The S&P 500 dropped 0.7 per cent to finish at 4,465.48, while the Nasdaq Composite

Winston Sammut, an investment manager for Euree Asset Management, discusses trends across property, valuations, risks of devaluation, M&A activity, and opportunities moving forward. Paul Sanger: We’re talking today with Winston Sammut, an investment manager at Euree Asset Management. Winston has over 40 years investment experience, including 20 years in the listed property industry. Winston was

At the closing bell, the S&P/ASX 200 was 0.78 per cent lower at 7,257.10. The price of iron ore has been steadily increasing, with recent futures pricing in Singapore pushing it past $115 per tonne. Today, iron ore futures for October contracts have risen by 1.1%, reaching $116.20 per tonne. This upward trend follows a

Typically, corporate fixed-interest fund raisings don’t make headlines, but when it’s BHP (ASX:BHP), the world’s largest mining company and a major player in financial markets, a substantial $US4.7 billion debt issuance demands close attention. BHP’s significant fundraising through a US bond issue occurred amid decidedly “non-normal” times. Interest rates have surged due to central banks’

In the span of just six weeks, Macquarie Group (ASX:MQG), the largest investment bank in the country, has experienced its second downgrade. The bank’s shares plummeted more than 3% following the recent update. Macquarie Group’s asset management division revised its short-term outlook, anticipating that returns from potential asset sales would extend into the latter half

Australia’s economic growth in the three months leading up to June, as well as for the 2022-23 financial year, was hindered by weaker household consumption. Nevertheless, the results surpassed many forecasts made prior to the release of the national accounts. The Australian Bureau of Statistics reported that GDP increased by 0.4% in the June quarter

Daniel Ortisi, Equity Research Analyst at Stock Doctor, discusses the winners and losers from reporting season and gives advice on portfolio positioning for FY24. Paul Sanger: Today we are looking back over the reporting season with Stock Doctor equity research analyst Daniel Ortisi. Stock Doctor is a platform that uses propriety quantitative mythology to provide